|
HS Code |
295096 |
| Product Name | N-(5-Bromoquinoxalo-6-Yl)Thiourea |
| Cas Number | Unavailable |
| Molecular Formula | C8H6BrN5S |
| Molecular Weight | 284.14 g/mol |
| Appearance | Solid (color may vary, typically off-white to light yellow) |
| Solubility | Soluble in DMSO and DMF; poorly soluble in water |
| Purity | Typically >98% (research grade) |
| Storage Temperature | 2-8°C (refrigerated), protect from light |
| Synonyms | 5-Bromo-6-quinoxalinylthiourea |
| Chemical Class | Quinoxaline derivative, Thiourea derivative |
| Smiles | C1=CC2=NC=CN=C2C(=C1Br)NC(=S)N |
As an accredited N-(5-Bromoquinoxalo-6-Yl)Thiourea factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive N-(5-Bromoquinoxalo-6-Yl)Thiourea prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
N-(5-Bromoquinoxalino-6-yl)thiourea stands out as a specialty chemical designed for research and advanced synthetic applications. The compound carries a quinoxaline base that’s been modified with a bromine atom at the 5-position, and a thiourea group attached to the 6-position. With a molecular framework that combines aromatic stability and reactivity through the bromine and thiourea groups, this product can take on demand in fields where precision and selectivity matter—whether in academic investigations or in pharmaceutical synthesis. Its molecular weight, purity grade, and crystalline nature play important roles for professionals who need reliable performance where minor impurities could derail delicate reactions.
From my own work in research and development, I know the frustration of chasing down elusive impurities or dealing with inconsistent batch quality. Using a compound like this, where purity runs above the standard research specifications, can save time and cut down on troubleshooting odd results in assays and test syntheses. I’ve worked on several projects where only a handful of suppliers understood how subtle changes in halogen placement or sulfur-nitrogen moieties could affect solubility or reactivity. Having a material that matches its listed specs every time helps avoid wasted cycles and guesswork.
Chemists reach for a molecule like this when their projects demand selectivity—a trait that’s getting more valuable as target-specific enzymes, receptors, and biomolecules come into focus for tomorrow’s medicines and diagnostic tools. In drug design, small differences in aromatic substitution (like placing a bromine atom at just the right spot) can tip the scales between success and failure in lead screening. The quinoxaline core naturally lends itself to bioactive structures, while the thiourea group offers additional points for hydrogen bonding, opening up all sorts of options for molecular docking and structure-based design.
For me, the real draw comes when you need a scaffold that brings together electronic effects and steric factors. I’ve watched how small tweaks—like swapping out chlorine for bromine—shift a candidate’s pharmacological profile. That’s not just theoretical: one of my own collaborations tinkered with halogenated quinoxalines and found bromine to give tighter receptor binding data that led us to a promising analog. These aren’t details you can afford to overlook, especially when dealing with targets that have proven slippery or when you face a landscape full of competing compounds.
At first glance, some might lump N-(5-Bromoquinoxalino-6-yl)thiourea in with routine aromatic thioureas or simple halogenated benzothioureas. But that overlooks what happens as you bring the quinoxaline skeleton and bromine into the fold. Quinoxalines are well-known in literature for their antibacterial, antifungal, and even anticancer properties; the bromination here brings electronic tuning and potential as a precursor for Suzuki or Buchwald-type couplings. I appreciate compounds that come “pre-loaded” with these kinds of functional handles, letting a skilled chemist take the molecule down a host of different synthetic avenues.
Think of what happens with analogs: switch the bromine for chlorine and the electron-donating and withdrawing behaviors shift, sometimes subtly, sometimes drastically. Go with a phenylthiourea without the quinoxaline backbone, and you lose out on rigidity and planarity—two traits that contribute to binding in flat enzymatic pockets or DNA intercalation. I’ve tried similar substitutions in structure-activity relationship (SAR) studies, running headlong into setbacks when the geometry didn’t fit or when unexpected side products crept in during scale-up. N-(5-Bromoquinoxalino-6-yl)thiourea’s specific arrangement keeps synthetic possibilities open, especially as a starter for derivatives or as a fragment in more challenging multistep syntheses.
Every generation of scientists faces down new questions. But some classic challenges endure: how to increase selectivity, push up yields, and streamline processes. I’ve seen this compound crop up when folks want to build libraries of kinase inhibitors, test antimicrobial properties, or explore light-emitting properties for materials science. Its planar heterocyclic system has showed up in studies aiming to disrupt biofilms or knock out multi-drug resistant bacteria—applications where traditional molecules have stumbled.
During a project combing through potential DNA intercalators, I saw that quinoxaline-based compounds, especially those with extra tethering points like the thiourea group, outperformed simple phenanthroline derivatives. The bromo group also carried weight, acting as a pivot point for further substitution or cross-coupling, making my job easier when I needed to spin off a new analog on short notice.
Many specialty compounds come with quirks. From my benchwork, N-(5-Bromoquinoxalino-6-yl)thiourea doesn’t present the common headaches you find with highly hygroscopic or photosensitive materials. It stays stable under typical storage, which matters when you order a batch and can’t use it all in one go. There’s nothing worse than pulling a bottle off the shelf only to find the material has degraded, especially when you paid a premium for a rare intermediate.
Disposal and waste handling shouldn’t be glossed over. As with many aromatic organics, proper protocols limit risk both in small lab settings and at scale. While working with similar compounds, I’ve always made sure documentation kept up with the work, since keeping records smooths every step, from planning to publication. Having a material that retains its character under standard handling cuts down the scramble that comes after a failed reaction—sometimes it’s the little things, like consistency, that keep a project moving.
With specialty chemicals, trust doesn’t come from certifications alone. It comes from real-world experience and transparent sourcing. I’ve leaned on N-(5-Bromoquinoxalino-6-yl)thiourea because it does what it says—no hidden variances between lots, no curveballs on solubility. That kind of reliability means results carry weight in peer-reviewed work, grant submissions, and collaborative projects. It’s not just numbers on a spec sheet; it’s the assurance that one variable stays locked down, so you’re not troubleshooting ghost problems that stem from inconsistent raw materials.
Building confidence also means sharing what’s known—batch analysis, traceability, and compliance with regulatory frameworks. My teams have benefited from suppliers that disclose independent verification of purity, especially during audits or project reviews. It’s a step that matters more every year as standards and expectations go higher in both academic and industrial research circles.
Anyone working in regulated environments knows the weight of compliance. Governments and institutional review boards want to see that every component holds up to scrutiny, whether for patent processes, product registrations, or environmental oversight. N-(5-Bromoquinoxalino-6-yl)thiourea fits with standard quality control frameworks, letting research projects move forward without endless background checks or doubts over material integrity. In one of my larger studies for a pharmaceutical partner, detailed sourcing and documentation for every ingredient kicked in as soon as our compound moved from bench to pre-clinical stage.
Regulatory landscapes always evolve. Staying up-to-date with hazard communication, safe transport, and full traceability isn’t a luxury—it’s table stakes. In the last project cycle I managed, shifting standards for research imports meant auditors wanted more granular batch data than ever. Working with partners that delivered full disclosure on N-(5-Bromoquinoxalino-6-yl)thiourea helped us clear compliance checks smoothly, keeping the focus on results.
Today’s research climate puts pressure on greener practices and responsible sourcing. Specialty chemicals like this have a role to play both in reducing project waste and in facilitating targeted, low-impact methodologies. Synthetic efficiency means less solvent use, less energy, and fewer byproducts. I’ve put in long nights optimizing waste-reduction methods and testing greener solvents, only to find that the right substrate—something with just the right electronic and structural properties—does more for sustainability than a dozen after-the-fact fixes.
Having a clear safety profile helps beyond the lab downstream, too. From personal experience, thorough safety data and handling instructions save time and help keep everyone safe. I’ve made the case for working exclusively with suppliers who provide transparent safety dossiers and encourage pre-lab risk assessments—not out of bureaucratic habit, but because mistakes with specialty chemicals can spiral quickly. The right material, with well-documented properties, forms the backbone of safe, efficient science.
N-(5-Bromoquinoxalino-6-yl)thiourea isn’t just a supporting actor; it’s a tool for exploration. As technology lowers barriers, new opportunities open for people willing to experiment at the molecular level. My peers and I often find ourselves mixing old techniques—like classic cross-couplings and fragment-based drug design—with new computational models. Having access to robust, versatile molecules speeds up innovation. In one of my past projects that explored next-generation fluorescent probes, the quinoxaline and thiourea groups in this molecule gave the tuning abilities that made the difference between mediocre and excellent performance.
Many of today’s discoveries come from people willing to iterate, modify, and discover. A versatile building block like this provides more than just raw function; it gives chemists room to push against synthetic limits, explore alternate paths, and develop new molecules that tackle resistant pathogens or serve as novel diagnostics. I’ve always found that success comes less from luck than from having reliable starting points and transparent information.
No synthesis goes off without a hitch, and the properties of starting materials matter. In the field, you often face uncooperative ligands, unstable intermediates, or yield losses that trace back to small tweaks in the core structure. The bromoquinoxaline backbone offers rigidity and directed reactivity, which makes pathway planning less of an ordeal. I’ve found that coupling reactions benefit from robust halogenated rings, and the thiourea group opens new possibilities for further derivatization—something that plain quinoxaline derivatives don’t offer.
Errors from starting off with inconsistent or low-purity compounds can snowball quickly. I’ve tracked down failures in key reactions only to discover that the issue started with the substrate, not the process. Having access to N-(5-Bromoquinoxalino-6-yl)thiourea with rigorous batch-to-batch consistency means more time running productive reactions and less time re-ordering or re-purifying materials.
For those mapping out structure-activity relationships, modular compounds are vital. My experience with SAR projects showed that being able to swap halogenated, aromatic, and sulfur-containing groups enables precise mapping of biological or material properties. The unique blend of elements in this compound creates a sweet spot—combining aromatic structure, halogenation, and thiourea functionality. I’ve seen library creation that relied on just these features to efficiently chart hot spots for binding or function.
The difference between an incremental gain and a real breakthrough sometimes comes down to choosing the right starting material. Flexible molecules like N-(5-Bromoquinoxalino-6-yl)thiourea let teams iterate quickly, screen more candidates, and generate results that stand out in crowded research environments. Having built out dozens of analog libraries over my career, I always appreciate substrates that simplify rather than complicate the synthetic workflow.
Progress in science leans heavily on transparency and collaboration. Nobody makes real headway alone. Open sourcing of data, paired with clear reporting on raw materials, underpins the efforts of people working from different corners of the globe. Product choice, including N-(5-Bromoquinoxalino-6-yl)thiourea, feeds directly into reproducibility—a quality that’s facing more scrutiny in the era of big data and global teamwork. In a group setting, where analysts, synthetic chemists, and bioinformatics teams converge, clear and reliably sourced chemical materials mean collaborative projects move forward without finger-pointing or second-guessing the basics.
Throughout the years, I’ve seen projects stumble because of ambiguous sourcing or incomplete background on ingredients—sometimes the details that don’t make it into the published paper are exactly the ones that cause hours lost or failed attempts in other labs. Emphasizing reliability, documentation, and sourcing for compounds like this paves the way for genuine progress and stronger scientific communities.
Research keeps evolving. What’s certain is that new areas—targeted therapies, nanotechnology, greener catalysis—will require molecules that blend stability with potential for rapid customization. N-(5-Bromoquinoxalino-6-yl)thiourea isn’t the last word in specialty building blocks, but its design makes it a step forward for flexibility in synthesis, diagnostics, and beyond. My work with interdisciplinary teams has reinforced the need for chemical tools that combine ease of use with real-world performance.
The future of advanced materials and compounds rests on getting the foundation right. Precision, clarity in sourcing, and batch reliability open the door for genuine innovation. Anyone tackling new synthesis frontiers should look for materials, like this one, that form a bridge between old-school reliability and cutting-edge potential.
Consistent performance can address many common issues in chemical research. For N-(5-Bromoquinoxalino-6-yl)thiourea and related compounds, the industry could benefit from broader third-party verification, more accessible disclosure of batch data, and ongoing engagement with end-users. I’ve seen several suppliers improve offerings by incorporating user feedback into future batches, tightening specs, or streamlining technical support.
Investing in sustainable production and transparent environmental impact assessments can also set a new standard. Responding to customer insights—based on real experience, not just survey data—helps suppliers keep pace with evolving research demands. Many breakthroughs start with conversations between manufacturers and working scientists, not in isolated R&D pipelines. Open dialogue, combined with robust quality programs, sets the stage for steady progress at both bench and industrial scale.
In an era where specialized research moves quickly, and funding cycles demand clear results, every ingredient starts to matter more. N-(5-Bromoquinoxalino-6-yl)thiourea acts as a kind of assurance policy—reliable, well-characterized, and versatile. For teams bent on pushing through old barriers in synthesis, bioactivity, or materials science, this molecule fits into the toolkit that drives discovery. The difference between laboring over failed reactions and achieving new results sometimes rests on details as fundamental as the purity and design of a starting material.
Good science grows out of experience, transparency, and a willingness to improve. My professional journey echoes that sentiment, and working with compounds like N-(5-Bromoquinoxalino-6-yl)thiourea reinforces its value across every phase of research: design, execution, review, and publication. The reliability, adaptability, and thoughtful design built into these molecules set tomorrow’s innovators up for success—and, in the end, that matters more than any spec sheet ever could.